Moderna Pivots Pipeline Toward Rare Diseases Amid Executive Reshuffle
Moderna forges a key partnership with Recordati to advance a therapy for propionic acidemia, while appointing a new Chief Development Officer as part of its strategic expansion beyond its COVID-19 vaccine roots.